Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) COO Rodolphe Herve sold 1,207 shares of Palomar stock in a transaction on Friday, July 31st. The stock was sold at an average price of $135.35, for a total transaction of $163,367.45. Following the transaction, the chief operating officer directly owned 3,548 shares of the company’s stock, valued at approximately $480,221.80. This trade represents a 25.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Palomar Stock Performance
Shares of NASDAQ PLMR traded down $0.40 during mid-day trading on Tuesday, reaching $136.11. 171,135 shares of the company were exchanged, compared to its average volume of 270,371. The stock has a market capitalization of $3.61 billion, a P/E ratio of 18.96 and a beta of 0.40. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. The company’s 50-day simple moving average is $124.76 and its 200-day simple moving average is $123.54. Palomar Holdings, Inc. has a twelve month low of $100.81 and a twelve month high of $147.62.
Palomar (NASDAQ:PLMR – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $2.36 EPS for the quarter, beating analysts’ consensus estimates of $2.19 by $0.17. The business had revenue of $314.42 million for the quarter, compared to analyst estimates of $621.52 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. As a group, research analysts predict that Palomar Holdings, Inc. will post 8.9 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Several research firms have recently commented on PLMR. Zacks Research downgraded Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. JPMorgan Chase & Co. upped their price objective on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a report on Monday, July 20th. Piper Sandler increased their price objective on Palomar from $132.00 to $165.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. Finally, Evercore set a $152.00 target price on Palomar in a report on Friday, July 10th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Palomar presently has a consensus rating of “Moderate Buy” and a consensus price target of $162.50.
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Further Reading
- Five stocks we like better than Palomar
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
